FDA recall D-0291-2026

Cipla USA, Inc. · Class III · drug

Product

Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39

Reason for recall

Failed PH Specifications

Distribution

Nationwide in the USA

Key facts

Status: Ongoing
Initiation date: 2025-12-22
Report date: 2026-01-28
Voluntary/Mandated: Voluntary: Firm initiated
Location: Warren, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0291-2026